Photo from wikipedia
Background: Renin angiotensin system inhibitors (RASi) are recommended (Class I LoE A ) for patients with coronary artery disease (CAD) without heart failure. However, more recent trials with improved background… Click to show full abstract
Background: Renin angiotensin system inhibitors (RASi) are recommended (Class I LoE A ) for patients with coronary artery disease (CAD) without heart failure. However, more recent trials with improved background therapy (and lower event rates) failed to show a benefit of RASi over active controls or
Keywords:
patients coronary;
artery disease;
coronary artery;
renin angiotensin;
angiotensin system;
system inhibitors
Journal Title: Journal of the American College of Cardiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!